The reddit post by AZgolfer99 that hoops just provided a link to is really worth reading. It gives a thoughtful and believable perspective on why medical personnel and institutions may be cool to leronlimab until there is more concrete data. Here's a couple quick quotes to give you the flavor of the post--

"Once we get the data that allows us to transmit a single, simple message like “reduces mortality by 50%”., we won’t need all the graphs about IL-6 and TNF alpha, etc. Until then, you need about 15-20 minutes of someone’s undivided attention and an interactive discussion where they can ask detailed questions if you expect them to really understand.....and that is assuming they are trained in medicine."

"I am aware of another CD12 study site that DID enroll a large number of patients and DID have a chance to see how patients did during the study. They have continued to enroll patients in the OLE after CD12 had completed enrollment. Their attention has been focused by the results they saw during the study......a good sign for Leronlimab."

Again, that's from AZgolfer99 from the reddit CYDY board, a self-described physician.

Thanks hoops for noticing this and providing the link